相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Pangenomic Classification of Pituitary Neuroendocrine Tumors
Mario Neou et al.
CANCER CELL (2020)
E-cadherin expression is associated with somatostatin analogue response in acromegaly
Eva Venegas-Moreno et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center
Adrian F. Daly et al.
ENDOCRINE CONNECTIONS (2019)
A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal
C. Villa et al.
VIRCHOWS ARCHIV (2019)
Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly
Eva Venegas-Moreno et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Germline mutations of aryl hydrocarbon receptor-interacting protein (AIP) gene and somatostatin receptor 1-5 and AIP immunostaining in patients with sporadic acromegaly with poor versus good response to somatostatin analogues
Hande Mefkure Ozkaya et al.
PITUITARY (2018)
Pathology of GH-producing pituitary adenomas and GH cell hyperplasia of the pituitary
Luis V. Syro et al.
PITUITARY (2017)
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
S. L. Asa et al.
ENDOCRINE-RELATED CANCER (2017)
Somatostatin receptor ligands in the treatment of acromegaly
Monica R. Gadelha et al.
PITUITARY (2017)
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study
Donato Iacovazzo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly
Annamaria Colao et al.
PITUITARY (2016)
A Structural and Functional Acromegaly Classification
Daniel Cuevas-Ramos et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Differential somatostatin receptor (SSTR) 1-5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors
Katja Kiseljak-Vassiliades et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Growth hormone tumor histological subtypes predict response to surgical and medical therapy
Katja Kiseljak-Vassiliades et al.
ENDOCRINE (2015)
Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodies
Laura Chinezu et al.
HUMAN PATHOLOGY (2014)
A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up
Jacqueline Trouillas et al.
ACTA NEUROPATHOLOGICA (2013)
Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations
Marie-Lise Jaffrain-Rea et al.
ENDOCRINE-RELATED CANCER (2013)
Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas
Sarah Larkin et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Molecular and functional properties of densely and sparsely granulated GH-producing pituitary adenomas
Bernhard Mayr et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly
Federico Gatto et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience
Jessica Brzana et al.
PITUITARY (2013)
Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly
Stine Lyngvi Fougner et al.
CLINICAL ENDOCRINOLOGY (2012)
Relationship between cytokeratin staining patterns and clinico-pathological features in somatotropinomae
Yuriz Bakhtiar et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
The Expression of E-Cadherin in Somatotroph Pituitary Adenomas Is Related to Tumor Size, Invasiveness, and Somatostatin Analog Response
Stine Lyngvi Fougner et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Pituitary somatostatin receptor signaling
Anat Ben-Shlomo et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
Expression Analysis of Dopamine Receptor Subtypes in Normal Human Pituitaries, Nonfunctioning Pituitary Adenomas and Somatotropinomas, and the Association between Dopamine and Somatostatin Receptors with Clinical Response to Octreotide-LAR in Acromegaly
Leonardo Vieira Neto et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Clinicopathological features of growth hormone-producing pituitary adenomas: Difference among various types defined by cytokeratin distribution pattern including a transitional form
Abdulkader Obari et al.
ENDOCRINE PATHOLOGY (2008)
Quantitative analysis of somatostatin receptor subtypes (1-5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR
Giselle F. Taboada et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Pathology of the human pituitary adenomas
Robert Y. Osamura et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2008)
Cell growth inhibition and functioning of human somatostatin receptor type 2 are modulated by receptor heterodimerization
Michael Grant et al.
MOLECULAR ENDOCRINOLOGY (2008)
The clinical response to somatostatin analogues in acromegaly correlates to the somatostatin receptor subtype 2a protein expression of the adenoma
Stine L. Fougner et al.
CLINICAL ENDOCRINOLOGY (2008)
Clinical review: The antitumoral effects of somatostatin analog therapy in acromegaly
JS Bevan
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity
M Rocheville et al.
SCIENCE (2000)